Effect of resveratrol on serum irisin and adiponectin in patients With type 2 diabetes

Phase 3

Completed

• Conditions: Type 2 Diabetes Mellitus.; non-insulin-dependent-diabetes-mellitus

• Registration Number: IRCT201601022394N19
• Lead Sponsor: Vice chancellor for research, Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

diagnosis of type 2 Diabetes for at least 2 years; willing to participate; BMI more than 25; age between 45 to 70 years old. Exclusion criteria: Significant diseases including cardiovascular, renal and liver diseases, or cancer; pregnancy; lactation; insulin use; weight and BMI change; consumption of nutritional supplements within the past 8 weeks.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Irisin. Timepoint: At baseline and after 8 weeks. Method of measurement: ELISA.;Adiponectin. Timepoint: At beaseline and after 8 weeks. Method of measurement: ELISA.

Secondary Outcome Measures

Name	Time	Method
Fasting Blood Sugar (FBS). Timepoint: At baseline and after 8 weeks. Method of measurement: Biochemical assessment.;HbA1C. Timepoint: At baseline and after 8 weeks. Method of measurement: Biochemical assessment.;Insulin. Timepoint: At baseline and after 8 weeks. Method of measurement: ELISA.